SEC Filing Details
Document Details
Form
Filing Date
Sep 24, 2019
Document Date
09/22/19
Form Description
Initial filing by director officer or owner of more than ten percent.
Filing Group
3,4,5
Company
Protalix BioTherapeutics
Issuer
PROTALIX BIOTHERAPEUTICS, INC.
Filer
Rubin Eyal